Sign Out
Studies in animals have shown developmental toxicity (see Pharmacology: Toxicology: Nonclinical safety data under Actions). The potential risk for humans is unknown. VYNDAMAX is not recommended during pregnancy. Women of childbearing potential should use appropriate contraception when taking VYNDAMAX and continue to use appropriate contraception for 1-month after stopping treatment with VYNDAMAX (see Use in Pregnancy & Lactation).
A study has not been conducted in organ transplant patients. The efficacy and safety of VYNDAMAX in organ transplant patients has not been established.
Effects on ability to drive and use machines: No studies on the effects of VYNDAMAX on the ability to drive or use machines have been performed.
